Evidence map›Paper›PMID 40594138›Full record

ArticleScientific reports2025

Altered miRNA expression in the lesions of cutaneous leishmaniasis caused by L. major and L. tropica with insights into apoptosis regulation.

Taha Masoudsinaki, Shima Hadifar, Hamzeh Sarvnaz, Mohammad Farahmand, Nasrin Masoudzadeh, Vahid Mashayekhi Goyonlo, Mohammadali Kerachian, Reza Erfanian Salim, Mourad Barhoumi, Seyed Latif Mousavi Gargari and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Non-coding RNAs as emerging players inFrontiers in cellular and infection microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Taha MasoudsinakiDepartment of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.
Shima HadifarDepartment of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.
Hamzeh SarvnazDepartment of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.
Mohammad FarahmandPediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Nasrin MasoudzadehDepartment of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.
Vahid Mashayekhi GoyonloCutaneous Leishmaniasis Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Mohammadali KerachianCutaneous Leishmaniasis Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Reza Erfanian SalimNoor Eye Hospital, Tehran, Iran.
Mourad BarhoumiMolecular Epidemiology and Experimental Pathology (MEEP)/LR16IPT04, Institut Pasteur de Tunis, Université de Tunis El Manar, Tunis, Tunisia.
Seyed Latif Mousavi GargariDepartment of Cell Biology, Faculty of Basic Sciences, Shahed University, Tehran, Iran. Slmousavi@shahed.ac.ir.
Hossein HeydariDepartment of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran. heydari_74@yahoo.com.
Sima RafatiDepartment of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran. s_rafati@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leishmaniasis is a vector-borne infectious disease that affects many subtropical countries. Leishmania (L.) major and L. tropica are among the old-world causative agents and cause cutaneous leishmaniasis (CL). The parasite utilizes various mechanisms to evade host immune responses and facilitate intracellular survival. Among these mechanisms, apoptosis inhibition through altering the host cell miRNA expression profile plays a significant role in parasite survival and infection progression. Based on the in-silico analysis through the miRDB database and literature review, miR-4795-3p, miR-6785-5p, miR-5011-5p, and miR-155-5p were selected as miRNAs regulating apoptosis-related genes. The expression of selected miRNAs was evaluated in the skin biopsy lesions collected from L. tropica and L. major-infected patients by qRT-PCR. Our results showed that miR-155-5p, miR-5011-5p, and miR-6785-5p were significantly upregulated (P < 0.05) in L. tropica-infected patients. Similar expression patterns for miR-155-5p and miR-6785-5p, but with a higher magnitude, were found in the lesions of CL patients infected with L. major. Additionally, miR-4795-3p expression level was downregulated in this group. The KEGG pathway analysis indicated that these miRNAs target several pathways that play key roles during leishmaniasis. The results underscore that further investigation is needed to better understand the regulatory roles of these miRNAs in CL infection.

Indexed as

ApoptosisLeishmania majorLeishmaniasis, CutaneousLeishmania tropicaMicroRNAsAdultFemaleGene Expression ProfilingGene Expression RegulationHumansMaleMicroRNAsApoptosisCutaneous leishmaniasisL. majorL. tropicaMiRNA

Identifiers

PMID40594138
PMCPMC12219827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.